Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
Aye WWT, Stark MR, Horne KL, Livingston L, Grenfell S, Myall DJ, Pitcher TL, Almuqbel MM, Keenan RJ, Meissner WG, Dalrymple-Alford JC, Anderson TJ, Heron CL, Melzer TR.
Aye WWT, et al. Among authors: keenan rj.
Alzheimers Dement (Amst). 2024 Jun 22;16(2):e12601. doi: 10.1002/dad2.12601. eCollection 2024 Apr-Jun.
Alzheimers Dement (Amst). 2024.
PMID: 38912306
Free PMC article.